nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinnarizine—HRH4—Histamine receptors—HRH3—narcolepsy	0.2	0.2	CbGpPWpGaD
Cinnarizine—HRH1—Histamine receptors—HRH3—narcolepsy	0.0758	0.0758	CbGpPWpGaD
Cinnarizine—HRH4—Amine ligand-binding receptors—HRH3—narcolepsy	0.031	0.031	CbGpPWpGaD
Cinnarizine—HRH4—GPCRs, Other—P2RY11—narcolepsy	0.029	0.029	CbGpPWpGaD
Cinnarizine—HRH4—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0155	0.0155	CbGpPWpGaD
Cinnarizine—DRD2—Amine ligand-binding receptors—HRH3—narcolepsy	0.012	0.012	CbGpPWpGaD
Cinnarizine—HRH1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0118	0.0118	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0112	0.0112	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0112	0.0112	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0108	0.0108	CbGpPWpGaD
Cinnarizine—HRH4—G alpha (i) signalling events—PENK—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Cinnarizine—CACNA1F—Alzheimers Disease—TNF—narcolepsy	0.00985	0.00985	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00919	0.00919	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—HCRTR1—narcolepsy	0.00852	0.00852	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—HCRTR2—narcolepsy	0.00852	0.00852	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—P2RY11—narcolepsy	0.00823	0.00823	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00819	0.00819	CbGpPWpGaD
Cinnarizine—HRH4—GPCRs, Other—HTR2A—narcolepsy	0.00817	0.00817	CbGpPWpGaD
Cinnarizine—HRH4—G alpha (i) signalling events—HRH3—narcolepsy	0.00768	0.00768	CbGpPWpGaD
Cinnarizine—DRD2—Monoamine GPCRs—HTR2A—narcolepsy	0.00711	0.00711	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—HCRT—narcolepsy	0.00699	0.00699	CbGpPWpGaD
Cinnarizine—HRH1—Monoamine GPCRs—HTR2A—narcolepsy	0.00698	0.00698	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00696	0.00696	CbGpPWpGaD
Cinnarizine—HRH1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00641	0.00641	CbGpPWpGaD
Cinnarizine—HRH1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00641	0.00641	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—PENK—narcolepsy	0.00623	0.00623	CbGpPWpGaD
Cinnarizine—HRH1—G alpha (q) signalling events—P2RY11—narcolepsy	0.00619	0.00619	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—HCRTR1—narcolepsy	0.00616	0.00616	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—HCRTR2—narcolepsy	0.00616	0.00616	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0061	0.0061	CbGpPWpGaD
Cinnarizine—DRD2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00598	0.00598	CbGpPWpGaD
Cinnarizine—HRH1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00587	0.00587	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00573	0.00573	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00573	0.00573	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00554	0.00554	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—TRH—narcolepsy	0.0053	0.0053	CbGpPWpGaD
Cinnarizine—HRH1—G alpha (q) signalling events—HCRT—narcolepsy	0.00526	0.00526	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00506	0.00506	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00506	0.00506	CbGpPWpGaD
Cinnarizine—DRD2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00505	0.00505	CbGpPWpGaD
Cinnarizine—DRD2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00505	0.00505	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00495	0.00495	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00495	0.00495	CbGpPWpGaD
Cinnarizine—DRD2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00487	0.00487	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—HCRTR1—narcolepsy	0.00481	0.00481	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—HCRTR2—narcolepsy	0.00481	0.00481	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00478	0.00478	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00471	0.00471	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—P2RY11—narcolepsy	0.00465	0.00465	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—HRH3—narcolepsy	0.00465	0.00465	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—HCRTR1—narcolepsy	0.00437	0.00437	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—HCRTR2—narcolepsy	0.00437	0.00437	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00432	0.00432	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00432	0.00432	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00424	0.00424	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00424	0.00424	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—P2RY11—narcolepsy	0.00422	0.00422	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00418	0.00418	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0041	0.0041	CbGpPWpGaD
Cinnarizine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.00403	0.00403	CbGpPWpGaD
Cinnarizine—HRH1—G alpha (q) signalling events—TRH—narcolepsy	0.00399	0.00399	CbGpPWpGaD
Cinnarizine—DRD2—G alpha (i) signalling events—PENK—narcolepsy	0.00398	0.00398	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—HCRT—narcolepsy	0.00395	0.00395	CbGpPWpGaD
Cinnarizine—CACNA1S—Alzheimers Disease—TNF—narcolepsy	0.00395	0.00395	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—TAC1—narcolepsy	0.00385	0.00385	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—NPS—narcolepsy	0.00385	0.00385	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—HCRT—narcolepsy	0.00359	0.00359	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00357	0.00357	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00355	0.00355	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—PENK—narcolepsy	0.00352	0.00352	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00349	0.00349	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—HCRTR2—narcolepsy	0.00329	0.00329	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—HCRTR1—narcolepsy	0.00329	0.00329	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—HCRTR1—narcolepsy	0.00323	0.00323	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—HCRTR2—narcolepsy	0.00323	0.00323	CbGpPWpGaD
Cinnarizine—CACNA1D—Alzheimers Disease—TNF—narcolepsy	0.00321	0.00321	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—PENK—narcolepsy	0.0032	0.0032	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—P2RY11—narcolepsy	0.00318	0.00318	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00316	0.00316	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—P2RY11—narcolepsy	0.00312	0.00312	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00311	0.00311	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00304	0.00304	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—TRH—narcolepsy	0.003	0.003	CbGpPWpGaD
Cinnarizine—DRD2—G alpha (i) signalling events—HRH3—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Cinnarizine—HRH1—G alpha (q) signalling events—NPS—narcolepsy	0.0029	0.0029	CbGpPWpGaD
Cinnarizine—HRH1—G alpha (q) signalling events—TAC1—narcolepsy	0.0029	0.0029	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—CHKB—narcolepsy	0.00286	0.00286	CbGpPWpGaD
Cinnarizine—CACNA1C—Alzheimers Disease—TNF—narcolepsy	0.00282	0.00282	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—NPS—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Cinnarizine—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—TRH—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0027	0.0027	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—HCRT—narcolepsy	0.0027	0.0027	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00269	0.00269	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—HCRT—narcolepsy	0.00265	0.00265	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00264	0.00264	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—HRH3—narcolepsy	0.00263	0.00263	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00259	0.00259	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00259	0.00259	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—HCRTR2—narcolepsy	0.00258	0.00258	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—HCRTR1—narcolepsy	0.00258	0.00258	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—CHKB—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—P2RY11—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—PENK—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—HRH3—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—PENK—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—HTR2A—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—TAC1—narcolepsy	0.00218	0.00218	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—NPS—narcolepsy	0.00218	0.00218	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—HCRT—narcolepsy	0.00212	0.00212	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—TRH—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—TRH—narcolepsy	0.00201	0.00201	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—TAC1—narcolepsy	0.00198	0.00198	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—NPS—narcolepsy	0.00198	0.00198	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—CPT1B—narcolepsy	0.00194	0.00194	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—PENK—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00186	0.00186	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00186	0.00186	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—P2RY11—narcolepsy	0.0018	0.0018	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—HRH3—narcolepsy	0.0018	0.0018	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—P2RY11—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—HRH3—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Cinnarizine—HRH1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—CPT1B—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—HCRTR1—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—HCRTR2—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—HCRTR2—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—HCRTR1—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—P2RY11—narcolepsy	0.00163	0.00163	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—TRH—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—P2RY11—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—HCRT—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—TNF—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—HCRT—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—TAC1—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—NPS—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—NPS—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—TAC1—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—CHKB—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—HRH3—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—HCRT—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Cinnarizine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—HCRT—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—PENK—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—PENK—narcolepsy	0.00134	0.00134	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—HTR2A—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—PENK—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—PENK—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.0012	0.0012	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—HTR2A—narcolepsy	0.00119	0.00119	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—NPS—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—TAC1—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—TRH—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—CHKB—narcolepsy	0.00114	0.00114	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—TRH—narcolepsy	0.00114	0.00114	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—TNF—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—TNF—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—TRH—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—CHKB—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—TRH—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00102	0.00102	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—HRH3—narcolepsy	0.00102	0.00102	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—HCRTR2—narcolepsy	0.000998	0.000998	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—HCRTR1—narcolepsy	0.000998	0.000998	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—HRH3—narcolepsy	0.000997	0.000997	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—HCRTR1—narcolepsy	0.00098	0.00098	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—HCRTR2—narcolepsy	0.00098	0.00098	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—P2RY11—narcolepsy	0.000964	0.000964	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—CPT1B—narcolepsy	0.000959	0.000959	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—P2RY11—narcolepsy	0.000946	0.000946	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—HRH3—narcolepsy	0.000922	0.000922	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—TNF—narcolepsy	0.000912	0.000912	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—HRH3—narcolepsy	0.000905	0.000905	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—HTR2A—narcolepsy	0.000896	0.000896	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—HTR2A—narcolepsy	0.000879	0.000879	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—TAC1—narcolepsy	0.000841	0.000841	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—NPS—narcolepsy	0.000841	0.000841	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—NPS—narcolepsy	0.000826	0.000826	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—TAC1—narcolepsy	0.000826	0.000826	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—HCRT—narcolepsy	0.00082	0.00082	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—HCRT—narcolepsy	0.000805	0.000805	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—CHKB—narcolepsy	0.000791	0.000791	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—CHKB—narcolepsy	0.000784	0.000784	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—CPT1B—narcolepsy	0.000773	0.000773	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—TAC1—narcolepsy	0.000764	0.000764	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—NPS—narcolepsy	0.000764	0.000764	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—TAC1—narcolepsy	0.00075	0.00075	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—NPS—narcolepsy	0.00075	0.00075	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—TNF—narcolepsy	0.00074	0.00074	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—PENK—narcolepsy	0.00073	0.00073	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—PENK—narcolepsy	0.000717	0.000717	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—CPT1B—narcolepsy	0.000714	0.000714	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—HTR2A—narcolepsy	0.000702	0.000702	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CHKB—narcolepsy	0.00067	0.00067	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—TNF—narcolepsy	0.000651	0.000651	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—TRH—narcolepsy	0.000621	0.000621	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—TRH—narcolepsy	0.00061	0.00061	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—HRH3—narcolepsy	0.000545	0.000545	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000538	0.000538	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—HRH3—narcolepsy	0.000535	0.000535	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—CPT1B—narcolepsy	0.000533	0.000533	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—HTR2A—narcolepsy	0.000506	0.000506	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—HTR2A—narcolepsy	0.000497	0.000497	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—HTR2A—narcolepsy	0.00046	0.00046	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CPT1B—narcolepsy	0.000455	0.000455	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—TAC1—narcolepsy	0.000451	0.000451	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—NPS—narcolepsy	0.000451	0.000451	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—HTR2A—narcolepsy	0.000451	0.000451	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—NPS—narcolepsy	0.000443	0.000443	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—TAC1—narcolepsy	0.000443	0.000443	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—HTR2A—narcolepsy	0.000271	0.000271	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—HTR2A—narcolepsy	0.000267	0.000267	CbGpPWpGaD
